HAMBURG (dpa-AFX) - The analyst firm Warburg Research has raised its target price for Drägerwerk from EUR 62 to EUR 64 and left its rating at "Buy". After the encouraging start to the year with a positive operating result (EBIT), he still sees a burden in the medical technology business due to the anti-corruption investigations and the focus on domestic devices in China, analyst Christian Ehmann wrote in a study published on Thursday. The decline in sales compared to the previous year should be lower in the second quarter than in the previous quarter and the order book should have grown faster. However, it is still too early to raise the outlook./gl/ajx

Publication of the original study: 20.06.2024 / 08:15 / CEST First dissemination of the original study: Date not specified in study / Time not specified in study / CEST

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------